Duodopa (levodopa/carbidopa intraduodenal gel infusion) / AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duodopa (levodopa/carbidopa intraduodenal gel infusion) / AbbVie
NCT02448914: A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients

Completed
1
11
Europe
TRIGEL, Lecigon, Duodopa, Duopa
LobSor Pharmaceuticals AB, TFS Trial Form Support
Parkinson's Disease
07/15
07/15
NCT02604914: A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

Completed
1
36
Europe
ND0612, (Levodopa-Carbidopa solution), LCIG, (Levodopa-Carbidopa Intestinal Gel)
NeuroDerm Ltd., Quotient Clinical
Parkinson's Disease
06/16
06/16
IPO-001, NCT03419806: Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease

Completed
1
25
Europe
Infudopa i.v., Infudopa IntraV, Infudopa s.c., Infudopa SubC, LCIG (Duodopa)
Vastra Gotaland Region, The Swedish Research Council, Dizlin Medical Design AB, Göteborg University
Parkinson Disease
03/20
04/20

Download Options